Your browser doesn't support javascript.
loading
Modification of BRCA1-associated breast cancer risk by HMMR overexpression.
Mateo, Francesca; He, Zhengcheng; Mei, Lin; de Garibay, Gorka Ruiz; Herranz, Carmen; García, Nadia; Lorentzian, Amanda; Baiges, Alexandra; Blommaert, Eline; Gómez, Antonio; Mirallas, Oriol; Garrido-Utrilla, Anna; Palomero, Luis; Espín, Roderic; Extremera, Ana I; Soler-Monsó, M Teresa; Petit, Anna; Li, Rong; Brunet, Joan; Chen, Ke; Tan, Susanna; Eaves, Connie J; McCloskey, Curtis; Hakem, Razq; Khokha, Rama; Lange, Philipp F; Lázaro, Conxi; Maxwell, Christopher A; Pujana, Miquel Angel.
Afiliación
  • Mateo F; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • He Z; Department of Pediatrics, University of British Columbia, Vancouver, BC, V6H 0B3, Canada.
  • Mei L; Department of Pediatrics, University of British Columbia, Vancouver, BC, V6H 0B3, Canada.
  • de Garibay GR; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • Herranz C; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • García N; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • Lorentzian A; Department of Pediatrics, University of British Columbia, Vancouver, BC, V6H 0B3, Canada.
  • Baiges A; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • Blommaert E; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • Gómez A; Department of Biosciences, Faculty of Sciences and Technology (FCT), University of Vic - Central University of Catalonia (UVic-UCC), Vic, 08500, Barcelona, Catalonia, Spain.
  • Mirallas O; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • Garrido-Utrilla A; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • Palomero L; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • Espín R; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • Extremera AI; ProCURE, Catalan Institute of Oncology, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • Soler-Monsó MT; Department of Pathology, University Hospital of Bellvitge, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • Petit A; Department of Pathology, University Hospital of Bellvitge, Oncobell, Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, 08908, Barcelona, Catalonia, Spain.
  • Li R; Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, 20037, USA.
  • Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology, Girona Biomedical Research Institute (IDIBGI), 17190, Girona, Catalonia, Spain.
  • Chen K; Department of Pediatrics, University of British Columbia, Vancouver, BC, V6H 0B3, Canada.
  • Tan S; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, V5Z 1L3, Canada.
  • Eaves CJ; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, V5Z 1L3, Canada.
  • McCloskey C; Princess Margaret Cancer Research Centre, University Health Network, Toronto, ON, M5G 2M9, Canada.
  • Hakem R; Princess Margaret Cancer Research Centre, University Health Network, Toronto, ON, M5G 2M9, Canada.
  • Khokha R; Department of Medical Biophysics, Faculty of Medicine, University Health Network, University of Toronto, Toronto, ON, M5G 1L7, Canada.
  • Lange PF; Princess Margaret Cancer Research Centre, University Health Network, Toronto, ON, M5G 2M9, Canada.
  • Lázaro C; Department of Medical Biophysics, Faculty of Medicine, University Health Network, University of Toronto, Toronto, ON, M5G 1L7, Canada.
  • Maxwell CA; Department of Pathology, University of British Columbia, Vancouver, BC, V6T 1Z7, Canada.
  • Pujana MA; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, Vancouver, BC, V6H 3N1, Canada.
Nat Commun ; 13(1): 1895, 2022 04 07.
Article en En | MEDLINE | ID: mdl-35393420
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteínas de la Matriz Extracelular / Receptores de Hialuranos / Proteína BRCA1 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Proteínas de la Matriz Extracelular / Receptores de Hialuranos / Proteína BRCA1 Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: España